» Articles » PMID: 38151750

Cardiovascular Risk of Dietary Trimethylamine Oxide Precursors and the Therapeutic Potential of Resveratrol and Its Derivatives

Overview
Journal FEBS Open Bio
Specialty Biology
Date 2023 Dec 27
PMID 38151750
Authors
Affiliations
Soon will be listed here.
Abstract

Overall diet, lifestyle choices, genetic predisposition, and other underlying health conditions may contribute to higher trimethylamine N-oxide (TMAO) levels and increased cardiovascular risk. This review explores the potential therapeutic ability of RSV to protect against cardiovascular diseases (CVD) and affect TMAO levels. This review considers recent studies on the association of TMAO with CVD. It also examines the sources, mechanisms, and metabolism of TMAO along with TMAO-induced cardiovascular events. Plant polyphenolic compounds, including resveratrol (RSV), and their cardioprotective mechanism of regulating TMAO levels and modifying gut microbiota are also discussed here. RSV's salient features and bioactive properties in reducing CVD have been evaluated. The close relationship between TMAO and CVD is clearly understood from currently available data, making it a potent biomarker for CVD. Precise investigation, including clinical trials, must be performed to understand RSV's mechanism, dose, effects, and derivatives as a cardioprotectant agent.

Citing Articles

Protective Effect of Resveratrol on Kidney Disease and Hypertension Against Microplastics Exposure in Male Juvenile Rats.

Tain Y, Chang-Chien G, Lin S, Hou C, Hsu C Antioxidants (Basel). 2025; 13(12.

PMID: 39765786 PMC: 11673385. DOI: 10.3390/antiox13121457.


Revisiting the Role of Carnitine in Heart Disease Through the Lens of the Gut Microbiota.

Demarquoy J Nutrients. 2024; 16(23.

PMID: 39683637 PMC: 11644639. DOI: 10.3390/nu16234244.


Resveratrol Butyrate Esters Reduce Hypertension in a Juvenile Rat Model of Chronic Kidney Disease Exacerbated by Microplastics.

Huang Y, Hsu C, Hou C, Chen S, Tain Y Nutrients. 2024; 16(23).

PMID: 39683469 PMC: 11643537. DOI: 10.3390/nu16234076.


Targeting Gut Microbiota with Probiotics and Phenolic Compounds in the Treatment of Atherosclerosis: A Comprehensive Review.

Cruz Neto J, de Luna Freire M, de Albuquerque Lemos D, Ribeiro Alves R, de Farias Cardoso E, de Moura Balarini C Foods. 2024; 13(18).

PMID: 39335815 PMC: 11431284. DOI: 10.3390/foods13182886.


The web of intrigue: unraveling the role of NETosis within the gut-microbiome-immune-heart axis in acute myocardial infarction and heart failure.

Yasuda T, Deans K, Shankar A, Chilton R Cardiovasc Endocrinol Metab. 2024; 13(3):e0309.

PMID: 39130369 PMC: 11315478. DOI: 10.1097/XCE.0000000000000309.

References
1.
Yao M, Liao P, Zhao X, Wang L . Trimethylamine-N-oxide has prognostic value in coronary heart disease: a meta-analysis and dose-response analysis. BMC Cardiovasc Disord. 2020; 20(1):7. PMC: 6953212. DOI: 10.1186/s12872-019-01310-5. View

2.
Guest I, Varma D . Selective growth inhibition of the male progeny of mice treated with trimethylamine during pregnancy. Can J Physiol Pharmacol. 1993; 71(2):185-7. DOI: 10.1139/y93-026. View

3.
El Assar M, Angulo J, Rodriguez-Manas L . Oxidative stress and vascular inflammation in aging. Free Radic Biol Med. 2013; 65:380-401. DOI: 10.1016/j.freeradbiomed.2013.07.003. View

4.
Dong Q, Wu Z, Li X, Yan J, Zhao L, Yang C . Resveratrol ameliorates cardiac dysfunction induced by pressure overload in rats via structural protection and modulation of Ca(2+) cycling proteins. J Transl Med. 2014; 12:323. PMC: 4278670. DOI: 10.1186/s12967-014-0323-x. View

5.
Ding L, Chang M, Guo Y, Zhang L, Xue C, Yanagita T . Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism. Lipids Health Dis. 2018; 17(1):286. PMC: 6300890. DOI: 10.1186/s12944-018-0939-6. View